Robbie G. Majzner
0000-0001-6969-8011
Publication & Citation Trends
Most Cited Works
Publications
234 total
Abstract 7814: Ganglioside targeting: Exerting sweet revenge on neuroblastoma
Cited by 0
Semantic Scholar
A framework for reparative CAR T engineering in the CNS
Cited by 0
Semantic Scholar
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.
Cited by 2
Semantic Scholar
312 Dissecting the immunobiology of off-the-Shelf, antigen-specific, CAR-T cells as therapy for DMG
Cited by 0
Semantic Scholar
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
Cited by 6
Semantic Scholar
Orientation-dependent CD45 inhibition with viral and engineered ligands 2152
Cited by 0
Semantic Scholar
In silico design of degron tags for precise modulation of CAR T-cell activity using clinically utilized drugs
Cited by 0
Semantic Scholar
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies OA
Cited by 10
Semantic Scholar
Research Topics
CAR-T cell therapy research
(150)
Virus-based gene therapy research
(79)
Cancer Research and Treatments
(66)
Immunotherapy and Immune Responses
(53)
Neuroblastoma Research and Treatments
(30)
Frequent Co-Authors
Affiliations
Boston University
Boston Children's Hospital
Cancer Prevention Institute of California
Harvard University
Palo Alto University